UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Lysophosphatidic Acid Provides a Missing Link Between Osteoarthritis and Joint Neuropathic Pain

Osteoarthritis and cartilage, 2017-06, Vol.25 (6), p.926-934

2017

Volltextzugriff (PDF)

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain

Osteoarthritis and cartilage, 2014-04, Vol.22 (4), p.578-585

2014

Volltextzugriff (PDF)

Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain

Osteoarthritis and cartilage, 2017-06, Vol.25 (6), p.935-942

2017

Volltextzugriff (PDF)

Lysophosphatidic acid contributes to the development of neuropathic pain in rodent knee joints

Osteoarthritis and cartilage, 2015-04, Vol.23, p.A354-A354

2015

Volltextzugriff (PDF)

Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage

Osteoarthritis and cartilage, 2010-07, Vol.18 (7), p.992-1000

2010

Volltextzugriff (PDF)

A selective RAR gamma antagonist relieves osteoarthritis like knee pain in the rodent

Osteoarthritis and cartilage, 2013-04, Vol.21, p.S289-S289

2013

Volltextzugriff (PDF)

Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia

The Journal of pharmacology and experimental therapeutics, 2016-03, Vol.356 (3), p.635

2016

Volltextzugriff (PDF)

Corrigendum to “Development of a novel antibody to Calcitonin Gene-Related Peptide for the treatment of osteoarthritis-related pain” [Osteoarthritis Cartilage 22 (2014) 578–585]

Osteoarthritis and cartilage, 2014-11, Vol.22 (11), p.1951-1951

2014

Volltextzugriff (PDF)

P69 EFFECTS OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST ANAKINRA, ON PAIN AND GROSS PATHOLOGY IN THE MONOIODOACETATEMODEL OF OSTEOARTHRITIS

Osteoarthritis and cartilage, 2006, Vol.14, p.S50-S51

2006

Volltextzugriff (PDF)

OSHA's approach to infectious disease problems in the dental office

Kentucky dental journal, 1989-03, Vol.41 (2), p.14

Oskins, D J

1989

Volltextzugriff (PDF)

Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis

Pain (Amsterdam), 2011-05, Vol.152 (5), p.975-981

2011

Volltextzugriff (PDF)

Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design

ACS medicinal chemistry letters, 2016-09, Vol.7 (9), p.857-861

2016

Volltextzugriff (PDF)

Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design

Bioorganic & medicinal chemistry letters, 2016-07, Vol.26 (14), p.3274-3277

2016

Volltextzugriff (PDF)

Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease

The New England journal of medicine, 2004-11, Vol.351 (20), p.2058-2068

2004

Volltextzugriff (PDF)

Sustained efficacy of intra-articular SB-061, a novel bioconjugate inspired by aggrecan, in a rat model of osteoarthritis

Osteoarthritis and cartilage, 2017-04, Vol.25, p.S415-S415

2017

Volltextzugriff (PDF)

Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists

Bioorganic & medicinal chemistry letters, 2016-05, Vol.26 (9), p.2303-2307

2016

Volltextzugriff (PDF)

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

The New England journal of medicine, 2003-04, Vol.348 (15), p.1425-1434

2003

Volltextzugriff (PDF)

Analgesic and anti‐inflammatory properties of novel, selective, and potent EP4 receptor antagonists

Pharmacology research & perspectives, 2017-06, Vol.5 (3), p.e00316-n/a

2017

Volltextzugriff (PDF)

Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile

Bioorganic & medicinal chemistry letters, 2016-02, Vol.26 (3), p.931-935

2016

Volltextzugriff (PDF)

Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design

Bioorganic & medicinal chemistry letters, 2016-07, Vol.26 (14)

2016

Volltextzugriff (PDF)

Compiler-Directed Cache Line Size Adaptivity

Intelligent Memory Systems, 2001, p.183-187

2001

Volltextzugriff (PDF)

Treatment of the hemophiliac with anti-VIII

Annals of the New York Academy of Sciences, 1975-01, Vol.240, p.407

1975

Volltextzugriff (PDF)

Home treatment for hemophilia

Pennsylvania medicine, 1974-12, Vol.77 (12), p.50

1974

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)
Tagungsberichte
(1)

Sprache

Englisch
(23)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(14)
Science & Technology
(14)
Humans
(12)
Male
(10)
Animals
(8)
Rheumatology
(8)
Rats
(7)
Pain
(6)
Pharmacology & Pharmacy
(6)
Osteoarthritis
(5)
Chemistry, Medicinal
(4)
Female
(4)
Middle Aged
(4)
Orthopedics
(4)
Rats, Inbred Lew
(4)
Aged
(3)
Arthritis, Experimental - Metabolism
(3)
Biological And Medical Sciences
(3)
Chemistry
(3)
Chemistry, Organic
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lysophosphatidic Acid Provides a Missing Link Between Osteoarthritis and Joint Neuropathic Pain

Development of a novel antibody to calcitonin gene-related peptide for the treatment of osteoarthritis-related pain

Identification and pharmacological characterization of a novel inhibitor of autotaxin in rodent models of joint pain

Lysophosphatidic acid contributes to the development of neuropathic pain in rodent knee joints

Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage

A selective RAR gamma antagonist relieves osteoarthritis like knee pain in the rodent

Identification and Characterization of Novel Microsomal Prostaglandin E Synthase-1 Inhibitors for Analgesia

Corrigendum to “Development of a novel antibody to Calcitonin Gene-Related Peptide for the treatment of osteoarthritis-related pain” [Osteoarthritis Cartilage 22 (2014) 578–585]

P69 EFFECTS OF THE INTERLEUKIN-1 RECEPTOR ANTAGONIST ANAKINRA, ON PAIN AND GROSS PATHOLOGY IN THE MONOIODOACETATEMODEL OF OSTEOARTHRITIS

OSHA's approach to infectious disease problems in the dental office

Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis

Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design

Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design

Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery Disease

Sustained efficacy of intra-articular SB-061, a novel bioconjugate inspired by aggrecan, in a rat model of osteoarthritis

Identification and biological activity of 6-alkyl-substituted 3-methyl-pyridine-2-carbonyl amino dimethyl-benzoic acid EP4 antagonists

Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism

Analgesic and anti‐inflammatory properties of novel, selective, and potent EP4 receptor antagonists

Discovery of potent aryl-substituted 3-[(3-methylpyridine-2-carbonyl) amino]-2,4-dimethyl-benzoic acid EP4 antagonists with improved pharmacokinetic profile

Identification of potent and selective retinoic acid receptor gamma (RARγ) antagonists for the treatment of osteoarthritis pain using structure based drug design

Compiler-Directed Cache Line Size Adaptivity

Treatment of the hemophiliac with anti-VIII

Home treatment for hemophilia

Suchergebnisse filtern